This activity is supported by an independent education grant from ArgenX. This online education program has been designed for healthcare professionals in the United States.
Diagnosing Pediatric Myasthenia Gravis (PMG) is challenging, particularly in younger children who frequently present with seronegative, fluctuating ocular symptoms. Led by Dr. Abigail N. Schwaede, this session provides a practical framework to recognize hallmark presentations, navigate diagnostic testing, and expedite specialist referrals.
Session Highlights
- Bedside Recognition: Spot fatigability, fluctuation, and asymmetry using high-yield bedside tests such as sustained upgaze, Cogan’s lid twitch, and the ice pack test.
- Differentiating Mimics: Distinguish PMG from congenital myasthenic syndromes (CMS), noting that pyridostigmine response and RNS decrements alone do not confirm autoimmunity.
- Stepwise Diagnostic Ladder: Navigate atypical and seronegative cases using a structured serology sequence, cell-based assays, and pediatric-adapted neurophysiology.
- Referral & Red Flags: Identify critical bulbar and respiratory warning signs requiring emergency care, and refer suspected cases promptly without waiting for antibody results.
Prefer to read? See our Key Clinical Summary Here.
Target Audience
This program is designed for healthcare professionals involved in the diagnosis, treatment, and longitudinal management of pediatric patients with pediatric myasthenia gravis (PMG). Relevant clinicians include pediatric and general neurologists, neuromuscular specialists, pediatricians, and advanced practice providers, including nurse practitioners and physician assistants.
Faculty
Dr. Abigail N. Schwaede, MD, is an Attending Physician in Neurology at Ann & Robert H. Lurie Children’s Hospital of Chicago and Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine. She specializes in pediatric neuromuscular disorders, with expertise in myasthenia gravis and other immune-mediated diseases, as well as Duchenne muscular dystrophy and spinal muscular atrophy. Her research focuses on electrodiagnostic tools and outcome measures in pediatric muscle diseases.
Disclosures
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Dr Abigail Schwaede has the following relevant financial relationships: Consultant, Advisor, Speaker: Biogen & Johnson and Johnson.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and MedAll. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Education
Partners designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 ANCC contact hours.
Pharmacy Continuing Education
Partners designates this continuing education activity for 0.5 contact hour(s) (0.5 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number - JA4008073-9999-26-365-H01-P
Type of Activity: Application
PA Continuing Medical Education
Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until October 15th 2027. PAs should only claim credit commensurate with the extent of their participation.
Interprofessional Continuing Education
This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credit for learning and change.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
This continuing education activity is active starting October 22nd 2026, and will expire on October 15th 2027.
Estimated time to complete this activity: 30 Minutes